SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001328143-20-000015
Filing Date
2020-02-25
Accepted
2020-02-25 16:20:29
Documents
5
Effectiveness Date
2020-02-25

Document Format Files

Seq Description Document Type Size
1 S-8 admss-82020filing.htm S-8 129866
2 EX-5.1 admss-82020ex51.htm EX-5.1 12861
3 EX-23.1 admss-82020ex231.htm EX-23.1 2821
4 image21.jpg GRAPHIC 10498
5 image31.jpg GRAPHIC 10498
  Complete submission text file 0001328143-20-000015.txt   164984
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-236619 | Film No.: 20650941
SIC: 2834 Pharmaceutical Preparations